IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 22.200
NA - Nord America 13.651
EU - Europa 4.634
SA - Sud America 1.684
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 182
OC - Oceania 61
AN - Antartide 1
Totale 42.598
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.154
US - Stati Uniti d'America 13.087
CN - Cina 3.001
IT - Italia 2.359
HK - Hong Kong 2.124
BR - Brasile 1.086
GB - Regno Unito 730
VN - Vietnam 603
FR - Francia 538
BD - Bangladesh 328
DE - Germania 274
CA - Canada 260
IN - India 238
AR - Argentina 173
NL - Olanda 156
MX - Messico 154
CO - Colombia 145
ID - Indonesia 116
EC - Ecuador 97
TR - Turchia 84
JP - Giappone 77
ZA - Sudafrica 76
FI - Finlandia 66
UA - Ucraina 64
VE - Venezuela 60
SA - Arabia Saudita 59
AU - Australia 55
ES - Italia 55
PH - Filippine 54
PL - Polonia 53
RU - Federazione Russa 48
IQ - Iraq 45
MY - Malesia 43
EE - Estonia 41
CL - Cile 37
SE - Svezia 34
PY - Paraguay 32
PK - Pakistan 31
MD - Moldavia 27
PE - Perù 27
UZ - Uzbekistan 27
CZ - Repubblica Ceca 26
JM - Giamaica 26
TH - Thailandia 24
CR - Costa Rica 23
CH - Svizzera 21
AT - Austria 20
BE - Belgio 17
AE - Emirati Arabi Uniti 16
GT - Guatemala 16
HN - Honduras 15
LT - Lituania 15
KE - Kenya 14
KR - Corea 14
NP - Nepal 14
TW - Taiwan 14
AZ - Azerbaigian 13
JO - Giordania 13
UY - Uruguay 13
BH - Bahrain 12
EG - Egitto 12
TN - Tunisia 12
IR - Iran 11
NI - Nicaragua 11
RO - Romania 11
MA - Marocco 10
TT - Trinidad e Tobago 10
DO - Repubblica Dominicana 9
IL - Israele 9
PS - Palestinian Territory 9
PT - Portogallo 9
RS - Serbia 9
SV - El Salvador 9
DZ - Algeria 8
SI - Slovenia 8
AL - Albania 7
BO - Bolivia 7
KZ - Kazakistan 7
OM - Oman 7
SY - Repubblica araba siriana 7
AM - Armenia 6
BG - Bulgaria 6
ET - Etiopia 6
GR - Grecia 6
IE - Irlanda 6
KW - Kuwait 6
LB - Libano 6
PR - Porto Rico 6
BA - Bosnia-Erzegovina 5
CI - Costa d'Avorio 5
QA - Qatar 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
BS - Bahamas 4
CY - Cipro 4
DM - Dominica 4
GH - Ghana 4
NZ - Nuova Zelanda 4
PA - Panama 4
SC - Seychelles 4
Totale 42.327
Salva come PNG Salva come JPEG
Città #
San Jose 3.143
Ashburn 2.895
Hong Kong 2.095
Singapore 1.977
Rome 1.393
Hefei 1.088
Council Bluffs 707
Boardman 659
Beijing 632
Columbus 561
London 512
Lauterbourg 473
Dallas 465
Shanghai 362
Santa Clara 323
Ho Chi Minh City 210
Los Angeles 203
Phoenix 188
New York 175
Hanoi 133
San Francisco 126
São Paulo 109
Munich 101
Amsterdam 91
Milan 87
Toronto 83
Pune 80
Mexico City 78
Seattle 77
Chicago 65
Washington 61
Brooklyn 54
Denver 52
Tokyo 51
Warsaw 48
Atlanta 43
Johannesburg 42
Montreal 42
Frankfurt am Main 41
Turku 40
Bogotá 39
Buffalo 38
Chennai 37
Naples 37
Rio de Janeiro 36
Las Vegas 35
Quito 32
Brasília 31
Philadelphia 31
St Louis 31
Boston 30
The Dalles 29
Orem 28
Turin 28
Melbourne 27
Bologna 26
Da Nang 26
Guayaquil 26
Riyadh 26
Stockholm 26
Helsinki 25
Charlotte 23
Medellín 23
Tashkent 23
Haiphong 22
Miami 22
Kuala Lumpur 21
Secaucus 21
Bari 20
Brno 20
Hangzhou 20
San José 20
The Bronx 20
Belo Horizonte 19
Biên Hòa 19
Buenos Aires 19
Florence 19
Istanbul 19
Manchester 19
Palermo 19
Jeddah 18
New Delhi 18
Porto Alegre 18
Ankara 17
Curitiba 17
Asunción 16
Dhaka 16
Genoa 16
Houston 16
Kingston 16
Sydney 16
Cleveland 15
Guangzhou 15
Santiago 15
Baghdad 14
Bangkok 14
Detroit 14
Modena 14
Caracas 13
Catania 13
Totale 20.908
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 347
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 311
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 288
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 269
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 266
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 266
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 262
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 258
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 257
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 254
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 252
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 249
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 247
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 244
Cardiotossicità da antracicline 243
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 242
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 241
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 239
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 237
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 235
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 233
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 232
Prevention of radiotherapy-induced emesis 229
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 228
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 228
Premetastatic niche: ready for new therapeutic interventions? 227
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 226
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 222
Urinary complications from breast cancer metastasis: case report and review of the literature 222
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 221
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 221
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 219
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 218
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 215
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 215
Docetaxel induced pericardial effusion 214
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 213
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 212
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 211
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 209
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 209
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 206
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 205
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 201
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 187
A giant sarcoma of the parotid gland: A case report and review of the literature 178
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 175
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 172
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 170
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 157
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 155
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 154
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 153
Italian translation of the Manchester-Oxford Foot Questionnaire (MOXFQ), with re-assessment of reliability and validity 151
'Old' and 'new' drugs for the treatment of cancer pain 151
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 151
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 150
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 149
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 149
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 149
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 147
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 146
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 146
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 145
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 141
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 141
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 140
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network 139
An international survey on the use of guidelines for palliative sedation therapy 138
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 137
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 137
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 137
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 135
Atypical chronic head and neck pain: don't forget Eagle's syndrome 135
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 133
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 132
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 132
Biological effects of cabozantinib on bone microenvironment 132
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 131
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 129
Azygo-tracheal fistula in a complete implantable central venous system 129
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 129
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 126
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 126
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 126
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 124
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 124
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 123
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 123
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 122
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 122
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 122
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 120
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 120
Idiosyncratic reaction after oxaliplatin infusion 119
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 119
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 119
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 118
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 114
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 111
Totale 18.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 288.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 288.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022732 0 0 0 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/202617.017 1.506 684 1.068 1.806 640 1.043 4.379 1.462 1.403 1.549 775 702
2026/20275.349 344 1.913 2.333 759 0 0 0 0 0 0 0 0
Totale 42.598